Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell TransplantationMichaël Philippe, Catherine Rioufol, Laure Lebras et al.|Transplantation and Cellular Therapy|2015Cited by 79
Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy programFlorent Charra, Florence Ranchon, Michaël Philippe et al.|Journal of Oncology Pharmacy Practice|2021Cited by 10
Epstein-Barr Virus (EBV) Reactivation, Its Treatment with Rituximab and Their Impact on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological MalignanciesMauricette Michallet, Franck‐Emmanuel Nicolini, Mohamad Sobh et al.|Blood|2016Cited by 4
Tacrolimus Extended Release Formulation Given As An Alternative To Ciclosporine A In Case Of Renal Impairment After Allogeneic HSCT: Results From a Prospective Pilot StudyMarie Y. Detrait, Fiorenza Barraco, Stéphane Morisset et al.|Blood|2013Cited by 0
Azacitidine Use in MDS and AML Patients: Best Selection for Better ResultsMauricette Michallet, Fiorenza Barraco, Mohamad Sobh et al.|Blood|2012Cited by 0